Pulmonary Nodule Localization Prospective Validation
1 other identifier
observational
50
1 country
1
Brief Summary
Localization is the key for successful excision of small target nodules under thoracoscopy, but the procedure also brings risks to patients. However, the criteria is still unclear. The investigators will validate the prediction model produced by institutional retrospective analysis in the prospective cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2020
CompletedFirst Posted
Study publicly available on registry
December 31, 2020
CompletedStudy Start
First participant enrolled
January 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedJanuary 26, 2021
January 1, 2021
11 months
December 28, 2020
January 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nodule detection
Whether the nodule could be detected by conventional visualization or palpation
During surgery
Interventions
Patients who are indicated for thoracoscopic nodulectomy.
Eligibility Criteria
Patients indicated for thoracoscopic nodulectomy
You may qualify if:
- Age ≧ 20 years
- Lung nodule size ≦2cm on the pre-operative computed tomography (CT)
- Nodulectomy is performed under thoracoscopy
You may not qualify if:
- Age \< 20 years
- Lung nodule size \> 2cm on CT or in the final pathology report
- Open surgery for nodulectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- E-DA Hospitallead
Study Sites (1)
E-DA Hospital
Kaohsiung City, 824, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ming-Wei Kao, M.D., M.S.
E-DA Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- president
Study Record Dates
First Submitted
December 28, 2020
First Posted
December 31, 2020
Study Start
January 23, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
January 26, 2021
Record last verified: 2021-01